CN1631184A - Method for inhibiting brown stain of low lactose milk and products thereof - Google Patents
Method for inhibiting brown stain of low lactose milk and products thereof Download PDFInfo
- Publication number
- CN1631184A CN1631184A CN 200310121748 CN200310121748A CN1631184A CN 1631184 A CN1631184 A CN 1631184A CN 200310121748 CN200310121748 CN 200310121748 CN 200310121748 A CN200310121748 A CN 200310121748A CN 1631184 A CN1631184 A CN 1631184A
- Authority
- CN
- China
- Prior art keywords
- milk
- lactose
- hmf
- content
- low
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000013336 milk Nutrition 0.000 title claims abstract description 104
- 239000008267 milk Substances 0.000 title claims abstract description 104
- 210000004080 milk Anatomy 0.000 title claims abstract description 104
- 239000008101 lactose Substances 0.000 title claims abstract description 92
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 title claims abstract description 72
- 238000000034 method Methods 0.000 title claims abstract description 48
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 16
- 230000001954 sterilising effect Effects 0.000 claims abstract description 48
- 238000004659 sterilization and disinfection Methods 0.000 claims description 40
- 102100026189 Beta-galactosidase Human genes 0.000 claims description 28
- 108010005774 beta-Galactosidase Proteins 0.000 claims description 28
- 108010059881 Lactase Proteins 0.000 claims description 26
- 229940116108 lactase Drugs 0.000 claims description 26
- 230000008569 process Effects 0.000 claims description 18
- 239000003112 inhibitor Substances 0.000 claims description 14
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 claims description 8
- 235000018417 cysteine Nutrition 0.000 claims description 6
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 6
- 230000007071 enzymatic hydrolysis Effects 0.000 claims description 6
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 claims description 6
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 4
- 235000010265 sodium sulphite Nutrition 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 abstract description 21
- 102000004190 Enzymes Human genes 0.000 abstract description 21
- NOEGNKMFWQHSLB-UHFFFAOYSA-N 5-hydroxymethylfurfural Chemical compound OCC1=CC=C(C=O)O1 NOEGNKMFWQHSLB-UHFFFAOYSA-N 0.000 description 80
- 230000007062 hydrolysis Effects 0.000 description 39
- 238000006460 hydrolysis reaction Methods 0.000 description 39
- 229940088598 enzyme Drugs 0.000 description 19
- 238000004519 manufacturing process Methods 0.000 description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 239000008103 glucose Substances 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 238000004128 high performance liquid chromatography Methods 0.000 description 10
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 9
- 235000013365 dairy product Nutrition 0.000 description 9
- 239000000047 product Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 201000010538 Lactose Intolerance Diseases 0.000 description 5
- 235000020247 cow milk Nutrition 0.000 description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 229930182830 galactose Natural products 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 3
- 235000006408 oxalic acid Nutrition 0.000 description 3
- 235000020185 raw untreated milk Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- RJGBSYZFOCAGQY-UHFFFAOYSA-N hydroxymethylfurfural Natural products COC1=CC=C(C=O)O1 RJGBSYZFOCAGQY-UHFFFAOYSA-N 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- -1 Sigma) Chemical compound 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 150000001728 carbonyl compounds Chemical class 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000019007 dietary guidelines Nutrition 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000020191 long-life milk Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Dairy Products (AREA)
Abstract
Disclosed is a method for inhibiting brown stain of low lactose milk and products thereof, wherein the method comprises, under the condition of pH=6.6-6.8, temperature of 8-9 deg. C, charging lactose enzyme into milk, wherein the enzyme consumption is 0.5-0.75%, the enzymolysis time 14-8 hours, charging suppressant an or B during the sterilizing procedure. The processed milk has the performance of low lactose.
Description
[ technical field]A method for producing a semiconductor device
The invention relates to a milk treatment method and a product obtained by the method, in particular to a method for inhibiting browning of low-lactose milk and non-browning milk obtained by the method. Belongs to the field of dairy products and dairy processing.
[ background of the invention]
The milk is the most ideal natural food for feeding young mammals, and is rich in high-quality protein, milk fat, lactose and other nutritional ingredients, calcium, phosphorus, potassium and other minerals and multiple vitamins. In developed countries, milk and dairy products have become important components of the diet of people; the newly revised dietary guidelines of Chinese residents in China clearly emphasize that 'one person cups milk (250ml) a day' and the WHO also lists the consumption of the average human milk products as a main index for measuring the living standard of people in a country. Thus, cow's milk has an important role in the diet of humans.
Although cow milk has excellent nutritional value, in China, the annual average consumption of dairy products in 2000 years is less than 10Kg and far lower than the annual average consumption (100Kg) of dairy products in the world. Besides the relative lag of the development and processing level of dairy industry in China, lactose intolerance also limits the popularization of dairy products in China to a certain extent.
The lactose content in cow milk is about 4.8% (considering rosy clouds, 2000), and it is more than 99% of total sugar in cow milk. Under normal physiological conditions, lactose is hydrolyzed into glucose and galactose by lactase in the small intestine, and then the glucose and the galactose can be absorbed by human bodies. Investigations have shown that about 70% of all people worldwide (especially in sub-non-countries) lack lactase, and these people, after taking cow's milk, have adverse reactions such as diarrhea and flatulence, i.e. lactose intolerance (Fox et al, 1992). Therefore, in the process of dairy processing, the lactose-reduced milk produced by degrading lactose with lactase not only can provide high-quality glycogen for people, but also can greatly increase the milk intake of people suffering from lactose intolerance.
Chinese patent CN1258452A discloses a method for producing low-lactose milk by using solid-phase thermophilic bacteria lactase, wherein temperature parameters and strain using methods of the method for producing the low-lactose milk by using the solid-phase thermophilic bacteria lactase are disclosed, but in the sterilization process, the carbonyl in the reduced sugar obtained by decomposition is combined with epsilon-amino in lysine, Maillard reaction occurs, and non-enzymatic browning is caused to the low-lactose milk. A qualified product cannot be obtained.
Because lactose is decomposed into glucose and galactose in the processing process of the low-lactose milk, on one hand, sweetness is increased, and the low-lactose milk is endowed with good taste and flavor; on the other hand, the carbonyl group in a large amount of reducing sugar combines with the epsilon-amino group in lysine to undergo maillard reaction, resulting in non-enzymatic browning of the low-lactose milk.
The first step of the maillard reaction is the reaction of amino groups with carbonyl groups in an open chain form to produce Schiff's base, followed by Amadori molecular rearrangement to produce N-substituted-1 amino-1-deoxy-2-ketose, which is colorless and does not absorb light near the ultraviolet region, and as the reaction proceeds, the material enolizes to 1, 2-monoalkanol or 2, 3-enediol, which ultimately forms 5-Hydroxymethylfurfural (5-hydroxymethylfurfurfurral, 5-HMF) (indigenous, 2001), the accumulation of 5-HMF has a strong correlation with browning (Ferrer et al, 2000), since 5-HMF can be cleaved to form α -dicarbonyl compounds, which carbonyl compounds react with amines to produce melanoidines (Morale et al, 1992), which is an important factor in the reduction of the degree of browning of dairy and HMF production.
The present invention utilizes lactase hydrolysis to produce low lactose milk, and utilizes HPLC method (Morales et al, 1992) to determine the content of 5-HMF, the main intermediate of Maillard reaction, and is based on the analysis of the influence of different production conditions and different inhibitors on the content of 5-HMF in low lactose milk. In addition, the invention also aims at measuring the color difference of the low-lactose milk obtained under different sterilization conditions and hydrolysis degrees, and analyzes the relationship between the color difference and the content of 5-HMF.
[ summary of the invention]
The invention aims to provide a method for processing milk, which has the characteristic of low lactose, inhibits the browning generated when sugar is decomposed, and has clean and fresh flavor;
it is another object of the present invention to provide a low lactose milk without browning.
The technical scheme adopted by the invention for solving the technical problems is as follows:
taking a certain amount of milk, adding lactase into the milk under the conditions that the pH is 6.6-6.8 and the temperature is 8-9 ℃, wherein the dosage of the lactase is 0.5-0.75 per mill (parts by weight), and the enzymolysis time is 14-8 hours; preferably, the enzymolysis is carried out for 14 hours by using 0.5 per mill (weight part) of enzyme, or for 8 hours by using 0.75 per mill (weight part) of enzyme.
High-temperature enzymolysis can also be carried out, namely, the enzyme dosage is 0.5 per mill to 0.75 per mill (weight part) at 37 to 40 ℃, the time is 3 to 2 hours, preferably, the enzymolysis is carried out for 3 hours at 37 ℃ by using 0.5 per mill (weight part) of enzyme dosage, orthe enzymolysis is carried out for 2 hours at 40 ℃ by using 0.75 per mill (weight part) of enzyme dosage; the hydrolysis rate can reach more than 70 percent, and the hydrolysis speed is high;
during the sterilization process, the operating parameters were selected as follows: sterilizing at 138-140 deg.C for 4.5-3.5 s;
the inhibitor sodium sulfite or cysteine is added during the sterilization process.
Considering the cost and the hydrolysis rate, the lactose-reduced milk is produced in the actual production, the lactose does not need to be completely decomposed, and when the hydrolysis rate of the lactose in the lactose-reduced milk reaches 70 percent, the problem of lactose intolerance can be solved. When the hydrolysis rate is about 70%, the content of 5-HMF is low. Thus, the hydrolysis rate of the lactose-reduced milk can be controlled to reduce the production of 5-HMF while meeting production requirements.
[ description of the drawings]
FIG. 1 is a process flow diagram for producing a browning free low lactose milk by degrading lactose in milk with lactase;
FIG. 2 shows the change of hydrolysis rate in low temperature enzymolysis (8-10 ℃);
FIG. 3 shows the change of hydrolysis rate in high temperature enzymolysis (37-40 ℃);
FIG. 4 shows the peak appearance of the spectrum of 5-HMF by HPLC;
FIG. 5 is a linear relationship between 5-HMF content (C5-HMF) and peak area (Aera);
FIG. 6 is a graph of the effect of hydrolysis rate on 5-HMF content in lactose-reduced milk;
FIG. 7 is the effect of sterilization temperature on 5-HMF content;
FIG. 8 effect of inhibitors on 5-HMF content in lactose-reduced milk at different sterilization temperatures;
FIG. 9 effect of inhibitors on 5-HMF content in lactose-reduced milk at different hydrolysis rates;
FIG. 10 shows 5-HMF content and color difference (Δ L) including specular reflection*、Δa*And Δ b*) The relationship of (1);
FIG. 11 shows 5-HMF content and color difference (. DELTA.L) when specular reflection is excluded*、Δa*And Δ b*) The relationship (2) of (c).
[ detailed description]embodiments
The following examples are given to illustrate the present invention in conjunction with the accompanying drawings, but are not intended to limit the scope of the present invention.
In the low lactose milk production process shown in fig. 1, 5-HMF is mainly generated in the sterilization stage, where the high temperature conditions are the main factors causing maillard reaction;
in fig. 2, the lactose-reduced milk is produced at low temperature, and when the enzyme dosage is 0.1 per mill and 0.25 per mill, the hydrolysis rate is lower in 4-16 hours; the enzyme dosage is 0.5 per mill and 0.75 per mill, the hydrolysis rate rises faster and reaches more than 70 percent in 14 hours and 8 hours respectively;
in fig. 3, the lactose-reduced milk is produced under the high-temperature condition, when the enzyme dosage is 0.1 per mill and 0.25 per mill, the hydrolysis rate is lower in 1-5 hours; the enzyme dosage is 0.5 per mill and 0.75 per mill, the hydrolysis rate rises faster and reaches more than 70 percent after 3 hours and 2 hours respectively;
as can be seen from FIG. 4, when the retention time is about 3.1min, the peak areas of the a peak, the b peak and the c peak increase sequentially with the increase of the injection concentration, i.e., the peaks of the a, b and c are 5-HMF after HPLC analysis.
The concentration of the sample is taken as the abscissa and the peak area is taken as the ordinate, a standard curve of 5-HMF is made, and a linear relation between the concentration and the peak area is obtained, and the result is shown in FIG. 5. The content of 5-HMF is expressed as C5-HMF, the linear equation is Aera ═ 14363C5-HMF +2.1617, and the correlation between the two is 99.89%.
After the pretreated sample to be detected is detected by an HPLC method, a peak area is obtained, and then the content of the 5-HMF in the sample can be obtained by calculation according to a standard curve shown in figure 5.
In the production process of the low-lactose milk, the content of reducing sugar is increased along with the increase of the hydrolysis rate. The effect of hydrolysis rate on 5-HMF content in post-sterilized lactose-reduced milk with sterilization at 139 ℃ for 4s is shown in figure 6.
As can be seen in FIG. 6, as the hydrolysis rate increased, the 5-HMF content increased in the lactose-reduced milk. The inventors have found that lactose intolerance can be resolved when the hydrolysis rate of lactose in low-lactose milk reaches 70%. As is clear from FIG. 6, the content of 5-HMF was low when the hydrolysis rate was about 70%. Thus, the hydrolysis rate of the lactose-reduced milk can be controlled to reduce the production of 5-HMF while meeting production requirements.
In the process of producing the low-lactose milk, the enzymolysis liquid needs to be treated at high temperature after the enzymolysis is finished, so as to achieve the purposes of enzyme deactivation and sterilization, thereby prolonging the shelf life. And the most prone to maillard reactions is the sterilization stage. Under high temperature sterilization conditions, the reducing sugars contained in the lactose-reduced milk react with the amino acid residues of the proteins to produce the intermediate 5-HMF of the maillard reaction. The effect of different sterilization temperatures and incubation times on the 5-HMF content of the lactose-reduced milk is shown in fig. 7.
As shown in fig. 7, both the sterilization temperature and time have an effect on the content of 5-HMF. The higher the sterilization temperature is, the more 5-HMF content is produced by the low-lactose milk; the longer the sterilization time, the higher the 5-HMF content. When producing the long-shelf-life sterilized milk, the actual production is performed by ultra-high temperature sterilization at 139 ℃, 4s or 135 ℃ and 15s, and as can be seen from fig. 7, when the sterilization conditions are 139 ℃ and 4s, the content of the generated 5-HMF is less.
It can be seen from figure 8 that at all sterilization temperatures, the 5-HMF content of the lactose-reduced milk after addition of the inhibitor was lower than the 5-HMF content of the lactose-reduced milk without any inhibitor added, even though the sterilization time was longer (15 s). After adding the inhibitor sodium sulfite or cysteine, the content of 5-HMF is less influenced by the sterilization temperature, but the effect of inhibiting the generation of 5-HMF by the cysteine is better.
The inventor analyzes the influence of the addition of the inhibitor on the content of 5-HMF in the lactose-reduced milk with different hydrolysis rates under the sterilization condition of 139 ℃ and 4s, and the result is shown in FIG. 9. As shown in FIG. 9, the 5-HMF content of the lactose reduced milk with differenthydrolysis rates was lower than that of the lactose reduced milk without any inhibitor added. As the hydrolysis rate increases, the increase of 5-HMF in the lactose-reduced milk after adding the inhibitor is lower than that of the product without the inhibitor, and cysteine has better effect of inhibiting the generation of 5-HMF under all conditions of the hydrolysis rate.
As shown in fig. 10, when specular reflection is included, the luminance value Δ L*The color of the lactose-reduced milk gradually deepens with the increase of the content of 5-HMF, and the color change can be observed by naked eyes. 5-HMF content and Δ L*There is a binomial relationship between them, and the 5-HMF content is expressed as C5-HMF, Δ L*And C5-HMF is: Δ L*The correlation reaches 99.44 percent when the molecular weight is-0.004 (C5-HMF)2-0.3154C5-HMF + 0.1381. And the redness value Deltaa*And yellowness index Δ b*Increasing with increasing 5-HMF content. Δ a*And C5-HMF as Δ a*The relativity of-0.0027 (C5-HMF)2+0.2697C5-HMF-0.1581 reaches 99.07%. Δ b*And C5-HMF as Δ b*0.0036(C5-HMF)2+0.2369C5-HMF-0.5693 with a correlation of 94.91%.
As shown in FIG. 11, the 5-HMF content and the color difference (. DELTA.L) were obtained while eliminating the specular reflection*、Δa*And Δ b*) The same trend exists as when specular reflection is involved. Brightness value DeltaL*Decreases with increasing 5-HMF content, the mathematical relationship between the two being Δ L*The correlation reaches 99.58 percent when the molecular weight is-0.0058 (C5-HMF) 2-0.3129C 5-HMF + 0.1389. Red value delta a*And yellowness index Δ b*Increasing with increasing 5-HMF content. Δ a*And C5-HMF as Δ a*-0.0024(C5-HMF)2+0.2854C5-HMF-0.1671 with a correlation of 99.15%. Δ b*And C5-HMF as Δ b*0.0063(C5-HMF)2+0.2371C5-HMF-0.6319 with a correlation of 95.56%.
From the above analysis, it can be seen that the 5-HMF content in the low-lactose milk is different from its color difference (. DELTA.L)*、Δa*And Δ b*) A binomial relationship exists. No matter the detection process is carried out, whether the specular reflection of the cuvette exists or not, the brightness value delta L of the lactose-reduced milk*The redness value Delta a decreases with increasing 5-HMF content*And yellowness index Δ b*Both increase with increasing 5-HMF content.
In order to clarify the relationship between the 5-HMF content and the color difference in the low-lactose milk, the inventor detected the color difference (Delta L) in the case of different 5-HMF contents*、Δa*And Δ b*) While the mathematical relationship between 5-HMF content and color difference was analyzed. FIG. 10 shows 5-HMF content and color difference (Δ L) including specular reflection*、Δa*And Δ b*) FIG. 11 shows the 5-HMF content and color difference (. DELTA.L) when specular reflection is excluded*、Δa*And Δ b*) The relationship (2) of (c).
Example 1
HPLC method for detecting 5-HMF
In the invention, the content of 5-HMF in milk is measured by an HPLC method. Three 5-HMF standards of different concentrations (1.1088. mu. mol/ml, 3.3264. mu. mol/ml, 6.6528. mu. mol/ml) were taken and analyzed by HPLC to determine the absorption at 280nm, in a sample volume of 20. mu.l.
Example 2
Relationship between 5-HMF content and color difference in low-lactose milk
The inventors analyzed the 5-HMF content of the lactose-reduced milk as a function of color difference to verify the feasibility of using the assay for 5-HMF content to monitor browning of the lactose-reduced milk.
Milk was hydrolyzed using lactase, samples were taken at 52.1%, 68.7%, 69.6% and 76.1% degrees of hydrolysis, respectively, and the resulting samples at different hydrolysis rates were subjected to two treatments: sterilizing at 85 deg.C for 15min and 121 deg.C for 10min, and determining 5-HMF content and color difference (Δ L) of each sample*、Δa*And Δ b*). The detection of color difference under two sterilization conditions respectively takes raw milk corresponding to the sterilization conditions as a standard sample. Sterilizing raw milk at 85 deg.CAfter 15min, L*=76.81,a*=-2.11,b*4.36; sterilizing raw milk at 121 deg.C for 10min, and collecting the milk*=73.02,a*=1.0,b*10.10. The content of 5-HMF in the low lactose sample obtained after enzymatic hydrolysis and the colour difference results are given in table 1:
TABLE 1 5-HMF and color difference values in lactose-reduced milk of different degrees of hydrolysis under two sterilization conditions
Rate of hydrolysis (%) | 52.1 | 68.7 | 69.6 | 76.1 | |
Sterilizing at 85 deg.C 15min | 5-HMF containing Amount (μ g/ml) | 0.573 9 | 1.0125 | 1.1691 | 1.8654 |
ΔL* Δa* Δb* | -0.11 -0.04 -0.16 | -0.15 -0.02 -0.15 | -0.17 -0.08 -0.31 | -0.25 -0.06 -0.28 | |
121 ℃ C Bacteria for 10min | 5-HMF containing Amount (μ g/ml) | 15.6547 | 18.3782 | 20.5214 | 22.0789 |
ΔL* Δa* Δb* | -7.39 3.88 5.44 | -8.11 4.28 6.0 | -8.84 4.51 6.8 | -8.91 4.52 6.12 |
As shown in Table 1, the 5-HMF content of the lactose-reduced milk was much higher than that of the milk sterilized at low temperature (85 ℃ for 15min) under the high temperature sterilization (121 ℃ for 10min), and the brightness value Δ L was also higher*Much lower than the value at low temperature sterilization. It can be seen that the lactose-reduced milk products have a darker color when sterilized at high temperatures, with the same hydrolysis rate.
Using the same method, the 5-HMF content and color difference were analyzed for lactose-reduced milk with a hydrolysis rate of 68.1% under different sterilization conditions, as shown in Table 2.
TABLE 2 5-HMF content and color difference in lactose-reduced milk under different sterilization conditions
Sterilization temperature (. degree.C.) Time (min) | 85~90℃ 15 min | 95~ 100℃ 15min | 110℃ 10min | 121℃ 10min | |
Low lactose milk (DH= 68.1%) | 5-HMF content (μg/ml) | 1.8654 | 2.0315 | 13.6835 | 22.078 9 |
ΔL* Δa* Δb* | -0.11 -0.04 -0.16 | -0.15 -0.02 -0.15 | -0.17 -0.08 -0.31 | -0.25 -0.06 -0.28 |
As can be seen from Table 2, the increased sterilization temperature increased the 5-HMF content of the lactose reduced milk and the lactose reduced milk product darkened in color.
As can be seen from tables 1 and 2, the 5-HMF content of the lactose-reduced milk varies greatly under different processing conditions, and the color difference varies with the 5-HMF content.
Example 3
The main apparatus is as follows: Shimadzu-HPLC, SPD-10AVP/10AVVP UV-visible detector, DGU-12A automatic degasser, and Rite SP62 spectrophotometer
Reagent: lactase (EC 3.2.1.23), 5-hydroxymethylfurfural (5-HMF, Sigma), methanol (Romil Chemicals, chromatographically pure), crystalline sodium acetate, acetic acid, trichloroacetic acid, oxalic acid, the inhibitor sodium sulfite and cysteine were all analytically pure, double distilled water.
Determination of lactose hydrolysis Rate
The lactose hydrolysis rate is determined by enzyme catalysis and by using a kit.
The principle is as follows: after one molecule of lactose in milk is hydrolyzed by lactase, one molecule of glucose and one molecule of galactose are generated, so that the glucose content in milk can be specifically detected by using a glucose oxidase-peroxidase method, and the hydrolysis rate of lactose can be known. Glucose is oxidized by glucose oxidase to generate gluconic acid and hydrogen peroxide, the hydrogen peroxide is further oxidized by oxidase to release nascent oxygen, the oxygen can oxidize colorless 4-aminoantipyrine (reduced type) into red quinoid compound (oxidized type) in the presence of phenol, the substance has maximum light absorption value at 505nm, and the shade of the color is in direct proportion to the glucose content in the sample. The reaction conditions are 37 ℃ and 15min, and the reaction process can be represented by the following formula:
the glucose content and lactose hydrolysis rate in the sample were calculated as follows:
glucose content (g/L) × (measurement tube absorbance/standard tube absorbance) × standard concentration in the sample
Lactose hydrolysis ratio (%) - (2 × glucose content in sample)/lactose content × 100%
Example 4
Determination of the conditions of the enzymatic hydrolysis
Lactose is hydrolyzed using lactase (EC 3.2.1.23) to produce a lactose-reduced milk. Simulating production conditions, performing low-temperature enzymolysis (8-10 ℃) and high-temperature enzymolysis (37-40 ℃), wherein the pH value is 6.6-6.8, and the enzyme dosage is 4 concentrations: 0.1%, 0.25%, 0.5%, 0.75%. Monitoring the change of the hydrolysis rate in 4-16 hours in the low-temperature enzymolysis process and the change of the hydrolysis rate in 1-5 hours in the high-temperature enzymolysis process, and then determining the enzyme dosage and the enzymolysis time.
Determination of 5-HMF content
The 5-HMF content was determined by HPLC (Morales et al, 1992).
The chromatographic conditions were as follows:
a chromatographic column: resolve C18 chromatography column (150 mm. times.4.0 mm, Daliyitet scientific instruments, Inc.)
Mobile phase: 0.1M pH3.8 sodium acetate buffer: methanol 92: 10
Detection wavelength: ultraviolet detector with wavelength of 280nm
Sample introduction amount: 20 μ l
Preparation of a standard solution: firstly, 0.056g of 5-HMF standard substance is dissolved, the volume is determined to 200ml to prepare stock solution, then 0.1ml, 0.3ml and 0.6ml of stock solution are respectively taken, 5ml of 0.15M oxalic acid, 3ml of 40 percent TCA and 10ml of 4 percent TCA are added, and then the volume is determined to 25 ml.
The sample pretreatment method refers to Ferrer (2000), and the specific flow is as follows: 5ml of 0.15M oxalic acid solution was added to 15ml of milk, mixed well, and heated in boiling water for 25 min. After the mixture was cooled to room temperature, 3ml of 40% TCA was added, shaken well, centrifuged (2000 Xg, 15min) and the supernatant collected. 10ml of 4% TCA was added to the centrifugation precipitate, mixed well and centrifuged (2000 Xg, 15min) to collect the supernatant. The supernatants from both centrifugations were combined, the volume was determined and then passed through a microfiltration membrane (0.45 μm), and the filtrate was assayed by HPLC.
Example 5
Color difference detection
The lactase is used for preparing the low-lactose milk, and the dosage of the lactase is 0.5 per mill.
The color difference of the resulting lactose-reduced milk samples was determined using a Rite SP62 spectrophotometer, USA. The method comprises the following steps: placing the spectrophotometer in a differential display mode, and then calibrating with a white standard; and (3) injecting the sample standard into a colorimetric pool, placing the colorimetric pool on a special colorimetric frame, firstly measuring the color difference of the standard sample, and then measuring the color difference of the sample by using the same method. By CIE L*a*b*Is the tolerance mode for chromatic aberration of the sample (Bertelli et al, 1996), L*Is a brightness value, a*Red value, b*Is a yellowness index, L*、a*And b*The change in (c) is calculated as follows:
ΔL*=L*-L*0(L*is the sample brightness value, L *0 is the brightness value of the standard sample
Δa*=a*-a*0(a*Is the sample redness value, a*0 is red value of standard sample)
Δb*=b*-b*0(b*Is the yellowness index of the sample, b *0 is a yellowness index of a standard sample
In the results obtained, if Δ L*If the sample brightness value is positive, the sample brightness value is higher than that of the standard sample, and the color is light; if Δ L*Negative indicates that the sample is lower in brightness value and darker in color than the standard sample.
Example 6
Taking a certain amount of milk, adding lactase into the milk under the conditions that the pH is 6.6 and the temperature is 9 ℃, wherein the enzyme dosage is 0.5 per mill (part by weight), and the enzymolysis time is 14 hours; during the sterilization process, the operating parameters were selected as follows: sterilized at 139 ℃ for 4 s.
Example 7
Taking a certain amount of milk, adding lactase into the milk under the conditions that the pH is 6.8 and the temperature is 9 ℃, wherein the enzyme dosage is 0.75 per mill (parts by weight), and the enzymolysistime is 8 hours; during the sterilization process, the operating parameters were selected as follows: sterilized at 138 ℃ for 4.5 s.
Example 8
A method for inhibiting browning of low lactose milk, comprising: taking a certain amount of milk, adding lactase into the milk under the conditions that the pH is 6.8 and the temperature is 8 ℃, wherein the enzyme dosage is 0.75 per mill (parts by weight), and the enzymolysis time is 8 hours; during the sterilization process, the operating parameters were selected as follows: sterilizing at 140 deg.C for 4.5 s.
Example 9
A method for inhibiting browning of low lactose milk, comprising: taking a certain amount of milk, adding lactase into the milk under the conditions that the pH is 6.6 and the temperature is 37 ℃, wherein the enzyme dosage is 0.75 per mill (parts by weight), and the enzymolysis time is 2 hours; during the sterilization process, the operating parameters were selected as follows: sterilized at 139 ℃ for 4 s.
Example 10
A method for inhibiting browning of low lactose milk, comprising: taking a certain amount of milk, adding lactase into the milk under the conditions that the pH is 6.6 and the temperature is 40 ℃, wherein the enzyme dosage is 0.5 per mill (part by weight), and the enzymolysis time is 14 hours; during the sterilization process, the operating parameters were selected as follows: sterilized at 139 ℃ for 4 s.
Example 11
A method for inhibiting browning of low lactose milk, comprising: taking a certain amount of milk, adding lactase into the milk under the conditions that the pH is 6.8 and the temperature is 40 ℃, wherein the enzyme dosage is 0.5 per mill (part by weight), and the enzymolysis time is 14 hours; during the sterilization process, the operating parameters were selected as follows: sterilized at 139 ℃ for 4 s. The invention has the following effects:
after a large number of experiments, the inventor obtains the optimal parameters through the selection of parameters, enzymolysis time and parameters, sterilization temperature and hydrolysis rate and the selection of an inhibitor, so that browning is well inhibited in the process of preparing the low-lactose milk, and the expected effect can be achieved.
Claims (7)
1. A method for inhibiting browning of low lactose milk, comprising: taking a certain amount of milk, adding lactase into the milk under the conditions that the pH is 6.6-6.8 and the temperature is 8-9 ℃, wherein the dosage of the lactase is 0.5-0.75 per mill (parts by weight), and the enzymolysis time is 14-8 hours; during the sterilization process, the operating parameters were selected as follows: sterilizing at 138-140 deg.C for 4.5-3.5 s.
2. The method of inhibiting browning of lactose-reduced milk according to claim 1 wherein the inhibitor sodium sulfite or cysteine is added during sterilization.
3. The method for inhibiting browning of low-lactose milk according to claim 1 or 2, wherein the amount of lactase is 0.5-0.75 per mill (parts by weight) under the enzymolysis condition of 37-40 ℃, and the enzymolysis time is 3-2 hours.
4. The method of inhibiting browning of a lactose-reduced milk according to claim 3, wherein said enzymatic hydrolysis conditions are 40 ℃, the lactase is used in an amount of 0.75% o by weight, and the enzymatic hydrolysis time is 2 hours.
5. The method of inhibiting browning of a lactose-reduced milk according to claim 3, wherein said enzymatic hydrolysis conditions are 37 ℃, the lactase is used in an amount of 0.5% by weight, and the enzymatic hydrolysis time is 3 hours.
6. A method of inhibiting browning of lactose-reduced milk according to claim 1 or 3 wherein the sterilization is carried out at 139 ℃ for 4 s.
7. A non-browning, low-lactose milk, characterised in that it is produced by a method according to any one of claims 1 to 6.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2003101217489A CN100441099C (en) | 2003-12-22 | 2003-12-22 | Method for inhibiting brown stain of low lactose milk and products thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2003101217489A CN100441099C (en) | 2003-12-22 | 2003-12-22 | Method for inhibiting brown stain of low lactose milk and products thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1631184A true CN1631184A (en) | 2005-06-29 |
CN100441099C CN100441099C (en) | 2008-12-10 |
Family
ID=34844259
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2003101217489A Expired - Lifetime CN100441099C (en) | 2003-12-22 | 2003-12-22 | Method for inhibiting brown stain of low lactose milk and products thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100441099C (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101034066B (en) * | 2007-02-03 | 2010-08-25 | 内蒙古伊利实业集团股份有限公司 | Method for testing lactose hydrolysis ratio in low lactose milk |
CN101228904B (en) * | 2008-02-26 | 2012-03-21 | 内蒙古蒙牛乳业(集团)股份有限公司 | Low-lactose milk and preparation method thereof |
CN102480979A (en) * | 2009-08-06 | 2012-05-30 | 东洋制罐株式会社 | Process for production of milk packed in container |
CN103891885A (en) * | 2012-12-25 | 2014-07-02 | 内蒙古蒙牛乳业(集团)股份有限公司 | Browning process of dairy product |
CN105685217A (en) * | 2010-07-23 | 2016-06-22 | 阿尔拉食品公司 | Lactose-reduced milk-related product, and a process and milk processing plant for its manufacture |
-
2003
- 2003-12-22 CN CNB2003101217489A patent/CN100441099C/en not_active Expired - Lifetime
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101034066B (en) * | 2007-02-03 | 2010-08-25 | 内蒙古伊利实业集团股份有限公司 | Method for testing lactose hydrolysis ratio in low lactose milk |
CN101228904B (en) * | 2008-02-26 | 2012-03-21 | 内蒙古蒙牛乳业(集团)股份有限公司 | Low-lactose milk and preparation method thereof |
CN102480979A (en) * | 2009-08-06 | 2012-05-30 | 东洋制罐株式会社 | Process for production of milk packed in container |
CN105685217A (en) * | 2010-07-23 | 2016-06-22 | 阿尔拉食品公司 | Lactose-reduced milk-related product, and a process and milk processing plant for its manufacture |
CN103891885A (en) * | 2012-12-25 | 2014-07-02 | 内蒙古蒙牛乳业(集团)股份有限公司 | Browning process of dairy product |
Also Published As
Publication number | Publication date |
---|---|
CN100441099C (en) | 2008-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jacob et al. | Comparison of various industrially applicable disruption methods to produce yeast extract using spent yeast from top-fermenting beer production: influence on amino acid and protein content | |
CN1882696A (en) | Method of determining substrate contained in hemoglobin-containing sample | |
Luo et al. | Development toward rapid and efficient screening for high performance hydrolysate lots in a recombinant monoclonal antibody manufacturing process | |
CN1875115A (en) | Method of assyaing glycoprotein | |
CN100336895C (en) | Double-microzyme secondary fermentation process for preparing Chinese goosebeery low-alcohol drink | |
CN109288014B (en) | Liquid fermentation method of eurotium cristatum of ginkgo and prepared product and application thereof | |
CN1280407C (en) | Lactobacillus pentosus strain, ferment produced thereby and the use of ferment in meat ware | |
KR100787633B1 (en) | Tea and Tea Manufacturing Method for Improving Liver Function and Curing of Hangover | |
CN116589533A (en) | Euphausia superba small molecule active peptide, and preparation method and application thereof | |
CN1631184A (en) | Method for inhibiting brown stain of low lactose milk and products thereof | |
CN1593646A (en) | Soybean peptide, its preparation and application | |
CN1268762C (en) | Corn peptide and its preparation and use | |
JP2016527886A (en) | Method for producing galactooligosaccharides reinforced with galactosyl lactose, a component of breast milk | |
CN1271201C (en) | Pediococcus pentosaceus strain, ferment produced thereby and the use of ferment in meat ware | |
CN114468042A (en) | Safe and efficient goat milk de-odoring agent | |
CN108192931B (en) | Method for preparing black garlic polyphenol by extracting black garlic through compound enzyme method | |
CN1297655C (en) | Staphylococcus xylosus I2 strain, composite ferment produced thereby and the use of ferment in meat ware | |
CN114369627B (en) | Method for producing lactic acid by promoting co-fermentation of kitchen waste and mushroom residue by aspergillus niger | |
US20140141122A1 (en) | Conversion of soybean hulls to ethanol and high-protein food additives | |
Kaewsedam et al. | Modulation of gut microbiota and their metabolites by functional mulberry juice non-thermally pasteurized using microfiltration | |
CN1252079C (en) | Novel substance having physiological activity, process for producing the same, and use | |
CN1264522C (en) | Medicinal composition, its preparation method and its use | |
Moges et al. | Glutamate oxidase advances in the selective bioanalytical detection of the neurotoxic amino acid β-ODAP in grass pea: A decade of progress | |
CN1732970A (en) | Breviscapine injection liquid and its preparing process | |
CN110564805A (en) | Fermentation preparation method of rabbit blood antioxidant peptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Zhou Weimingsheguoqing Document name: Notification before expiration of term |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Zhou Weimingsheguoqing Document name: Notice of first review |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20081210 |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Zhou Weiming Document name: Notice of Termination of Patent Rights |